The Valley Desk

NCT05500222 · Interventional trial

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

Overall registry status Active not recruiting

Phase 3

Conditions Cirrhosis, Liver, NASH

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov